Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance
- 10 February 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 9 (3) , 305-313
- https://doi.org/10.1089/hum.1998.9.3-305
Abstract
This study assessed the mucosal and systemic immune responses following repetitive adenoviral vector instillation to the parotid glands. Also, we investigated the feasibility of oral tolerance induction as a rational strategy to overcome the immunological reactions. The replication-deficient recombinant adenovirus vector Ad-CMVCAT was instilled into rat parotid glands. Chloramphenicol acetyltransferase (CAT) activity in the parotid was observed after a first or second AdCMVCAT infection, but not after a third vector administration. ELISA assays showed increased anti-adenovirus immunoglobulin G (IgG) and IgM in serum, and also anti-adenovirus IgA in gland extracts and saliva after virus administration. The results of in vivo neutralization experiments demonstrated that salivary IgA and IgM prevented reinfection of the parotids with adenoviral vectors. Subsequently, studies were conducted to induce tolerance to adenovirus by peroral feedings of ultraviolet (UV)-inactivated virus before gene administration to the parotid glands. Between 3 and 13 doses of virus were fed to rats. Final parotid gene expression was dependent on the number of viral feedings and the amount fed. Tolerized animals showed prolonged and heightened gene expression in the salivary glands compared to control animals and displayed gene expression even after three administrations of vector. Mononuclear cells from the spleens of these animals showed reduced proliferation following adenovirus stimulation. This same cell population was depleted of CD8+ T cells and found to produce less interferon-γ (IFN-γ) after virus challenge. This profile indicates the down regulation of Th1 cell-mediated responses. These results indicate that oral tolerance induction is a potentially useful adjunct to virus-based gene therapy. Immune responses to adenoviral vectors represent a major limitation to their use in vivo, particularly when repeated administration is required. In rat parotid gland, gene expression was observed after a first or second virus instillation, but not after the third administration. Those animals showed elevated serum anti-adenovirus immunoglobulin G (IgG) and IgM levels and anti-adenovirus IgA level in saliva. Animals were fed inactivated vector to determine if immunological tolerance could be induced. The orally tolerized animals showed prolonged gene expression in the salivary glands compared to control animals, and could be infected at least three times. The immunological profile of these animals suggested a down-regulation of the Th1 cell-mediated response.This publication has 34 references indexed in Scilit:
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- Immediate Inflammatory Responses to Adenovirus-Mediated Gene Transfer in Rat Salivary GlandsHuman Gene Therapy, 1996
- Dose‐dependent Activation and Deletion of Antigen‐specific T Cells following Oral ToleranceAnnals of the New York Academy of Sciences, 1996
- Induction of Tolerance in Humans.Annals of the New York Academy of Sciences, 1996
- Pulmonary Inflammation Induced by Incomplete or Inactivated Adenoviral ParticlesHuman Gene Therapy, 1995
- FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1995
- Gene Transfer to the Thymus A Means of Abrogating the Immune Response to Recombinant AdenovirusAnnals of Surgery, 1995
- Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus andβ-GalactosidaseHuman Gene Therapy, 1995
- Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2aHuman Gene Therapy, 1994
- Expression of human α1‐antitrypsin using a recombinant adenovirus vectorFEBS Letters, 1990